Cellectis (CLLS) Share-based Compensation (2016 - 2023)
Historic Share-based Compensation for Cellectis (CLLS) over the last 9 years, with Q4 2023 value amounting to $4.6 million.
- Cellectis' Share-based Compensation rose 109405.68% to $4.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.2 million, marking a year-over-year decrease of 1340.39%. This contributed to the annual value of $3.2 million for FY2024, which is 3948.02% down from last year.
- Latest data reveals that Cellectis reported Share-based Compensation of $4.6 million as of Q4 2023, which was up 109405.68% from -$2.7 million recorded in Q3 2023.
- In the past 5 years, Cellectis' Share-based Compensation registered a high of $8.0 million during Q3 2019, and its lowest value of -$2.8 million during Q4 2020.
- Moreover, its 5-year median value for Share-based Compensation was $2.8 million (2020), whereas its average is $3.0 million.
- In the last 5 years, Cellectis' Share-based Compensation soared by 762000.0% in 2022 and then crashed by 29962.38% in 2023.
- Quarter analysis of 5 years shows Cellectis' Share-based Compensation stood at $7.1 million in 2019, then plummeted by 139.19% to -$2.8 million in 2020, then skyrocketed by 169.53% to $1.9 million in 2021, then tumbled by 79.98% to $387000.0 in 2022, then skyrocketed by 1094.06% to $4.6 million in 2023.
- Its last three reported values are $4.6 million in Q4 2023, -$2.7 million for Q3 2023, and $1.6 million during Q2 2023.